Advancements in targeted therapies, immunotherapy under clinical investigation, and precision oncology tools are driving growth in the locally advanced pancreatic cancer treatment market, with improved surgical outcomes and patient stratification through 2033. https://www.datamintelligence.com/research-report/locally-advanced-pancreatic-cancer-market